UKCTOCS (UK Collaborative Trial of Ovarian Cancer Screening) is one of the largest screening trials in ovarian cancer. More than 200,000 women from England, Wales and Northern Ireland took part in it, and it ran for almost two decades. Designing and running such a large and lengthy trial came with its own challenges. In this episode, Professor Usha Menon discusses the key challenges that UKCTOCS faced in its design, conduct an analysis, and how the team addressed them.

Further information is available on the UKCTOCS website at https://ukctocs.mrcctu.ucl.ac.uk/
Listen to the episode about the UKCTOCS trial results at https://bit.ly/48pK94J
For questions or feedback on the series, message us at mrcctu.engage@ucl.ac.uk
For more information and to access the transcript: https://bit.ly/45XRyWT
As a listener, your opinion is very valuable to us. Please help us to improve the podcast in the future by filling in this short survey: forms.office.com/e/PjfjQ5Mn6g

Lessons from UKCTOCS, a large-scale trial in ovarian cancer screening

UCL (University College London) is consistently ranked among the world's top ten universities (QS World University Rankings 2010 - 2021). Our excellence extends across all academic disciplines, from one of the world's foremost centres for research and teaching in the biological sciences to world-renowned centres for architecture (UCL Bartlett), education (UCL IOE) and fine art (UCL Slade School).

UCL is London's leading multidisciplinary university, with more than 13,000 staff and 43,000 students from 150 different countries. Founded in 1826 in the heart of London, UCL was the first university in England to welcome students of any religion and the first to welcome women on equal terms with men.

UCL Minds brings together UCL’s knowledge, insights, and ideas through events, activities, and digital content open to everyone. Find out what’s on UCL Minds: www.ucl.ac.uk/minds

The Trial Talk podcast explores how our work at the MRC Clinical Trials Unit at UCL is improving health in the UK and worldwide. In this series, we hear from world-leading experts about the studies we carry out. We delve into trials on cancer, infections and neurodegenerative diseases, explore how public and patient involvement shapes our work, and discover new ways to run smarter studies.

Lessons from UKCTOCS, a large-scale trial in ovarian cancer screening

MRC CTU at UCL - Trial Talk podcast